REFERENCES
- Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689–693.
- Jabs DA, Houk JL, Bias WB, Arnett FC. Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med. 1985;78:801–804.
- Tromp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet. 1996;59:1097–1107.
- Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19–20. doi:10.1038/ng720.
- Kanazawa N, Okafuji I, Kambe N, et al. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 2005;105:1195–1197. doi:10.1182/blood-2004-07-2972.
- Rose CD, Martin TM, Wouters CH. Blau syndrome revisited. Curr Opin Rheumatol. 2011;23:411–418. doi:10.1097/BOR.0b013e328349c430.
- Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin Immunol. 2010;134:251–261. doi:10.1016/j.clim.2009.05.005.
- Sarens IL, Casteels I, Anton J, et al. Blau syndrome-associated uveitis: preliminary results from an international prospective interventional case series. Am J Ophthalmol. 2018;187:158–166. doi:10.1016/j.ajo.2017.08.017.
- Wang W, Wei M, Song H, Qiu Z. [Mutations of NOD2 gene and clinical features in Chinese Blau syndrome patients]. Zhonghua Er Ke Za Zhi. 2014;52:896–901.
- Caso F, Costa L, Rigante D, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014;13:1220–1229. doi:10.1016/j.autrev.2014.08.010.
- Okafuji I, Nishikomori R, Kanazawa N, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheumatol. 2009;60:242–250. doi:10.1002/art.24134.
- Saulsbury FT, Wouters CH, Martin TM, et al. Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree. Arthritis Rheum. 2009;60:1804–1806. doi:10.1002/art.24532.
- Harada J, Nakajima T, Kanazawa N. A case of blau syndrome with NOD2 E383K mutation. Pediatr Dermatol. 2016;33:e385–e387. doi:10.1111/pde.12908.
- Rose CD. Blau syndrome: a systemic granulomatous disease of cutaneous onset and phenotypic complexity. Pediatr Dermatol. 2017;34:216–218. doi:10.1111/pde.13021.
- Ebrahimiadib N, Samra KA, Domina AM, et al. A novel NOD2-associated mutation and variant blau syndrome: phenotype and molecular analysis. Ocular Immunology Inflammation. 2018;26:57–64. doi:10.1080/09273948.2016.1185529..
- Milman N, Ursin K, Rodevand E, Nielsen FC, Hansen TVO. A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members. Scand J Rheumatol. 2009;38:190–197. doi:10.1080/03009740802464194.
- Osborne GE, Mallon E, Mayou SC. Juvenile sarcoidosis after BCG vaccination. J Am Acad Dermatol. 2003;48:S99–102. doi:10.1067/mjd.2003.158.
- Kim TH, Payne U, Zhang X, et al. Altered host: pathogeninteractions conferred by the Blau syndrome mutation of NOD2. Rheumatol Int. 2007;27:257–262. doi:10.1007/s00296-006-0250-0.
- Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371–382. doi:10.1038/nri1086.
- Glass DA 2nd, Maender J, Metry D. Two pediatric cases of Blau syndrome. Dermatol Online J. 2009;15:5.
- Arvesen KB, Herlin T, Larsen DA, et al. Diagnosis and treatment of blau syndrome/early-onset sarcoidosis, an autoinflammatory granulomatous disease, in an infant. Acta Derm Venereol. 2017;97:126–127. doi:10.2340/00015555-2485.
- Simonini G, Xu Z, Caputo R, et al. Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheumatol. 2013;65:513–518. doi:10.1002/art.37776.
- Martin TM, Zhang Z, Kurz P, et al. The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheumatol. 2009;60:611–618. doi:10.1002/art.24222.
- Lu L, Shen M, Jiang D, et al. Blau syndrome with good Reponses to Tocilizumab: A case report and focused literature review. Semin Arthritis Rheum. 2018;47:727–731. doi:10.1016/j.semarthrit.2017.09.010.